�ݺ�ߣshows by User: YogeshShilimkar

�ݺ�ߣshows by User: YogeshShilimkar / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: YogeshShilimkar / Sun, 27 Mar 2022 12:48:49 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: YogeshShilimkar OCT.pptx /slideshow/octpptx/251439165 oct-220327124849
Optical coherence tomography (OCT) uses near-infrared light to generate high-resolution images of coronary arteries in vivo. The near-infrared light with a wavelength of about 1.3 μm is invisible to the human eye. To generate cross-sectional images, OCT uses low-coherence interferometry by measuring the echo time delay and intensity of the light reflected from internal structures in tissue. ]]>
Optical coherence tomography (OCT) uses near-infrared light to generate high-resolution images of coronary arteries in vivo. The near-infrared light with a wavelength of about 1.3 μm is invisible to the human eye. To generate cross-sectional images, OCT uses low-coherence interferometry by measuring the echo time delay and intensity of the light reflected from internal structures in tissue. ]]> Sun, 27 Mar 2022 12:48:49 GMT /slideshow/octpptx/251439165 YogeshShilimkar@slideshare.net(YogeshShilimkar) OCT.pptx YogeshShilimkar Optical coherence tomography (OCT) uses near-infrared light to generate high-resolution images of coronary arteries in vivo. The near-infrared light with a wavelength of about 1.3 μm is invisible to the human eye. To generate cross-sectional images, OCT uses low-coherence interferometry by measuring the echo time delay and intensity of the light reflected from internal structures in tissue. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/oct-220327124849-thumbnail.jpg?width=120&height=120&fit=bounds" /> Optical coherence tomography (OCT) uses near-infrared light to generate high-resolution images of coronary arteries in vivo. The near-infrared light with a wavelength of about 1.3 μm is invisible to the human eye. To generate cross-sectional images, OCT uses low-coherence interferometry by measuring the echo time delay and intensity of the light reflected from internal structures in tissue.

OCT.pptx from Yogesh Shilimkar

]]> 713 0 https://cdn.slidesharecdn.com/ss_thumbnails/oct-220327124849-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Contrast-induced nephropathy.pptx /slideshow/contrastinduced-nephropathypptx/251439104 contrast-inducednephropathy-220327123529
Radiographic Contrast Agents And Contrast-induced Nephropathy All contrast agents have a basic structure of a benzene ring, which is composed of 6 joined carbon atoms, each of which has an attached hydrogen atom. Contrast media consist of triiodinated benzene rings, whereby 3 hydrogen atoms are replaced with attached iodine atoms. Monomers contain 1 triiodinated benzene ring, and dimers contain 2 triiodinated benzene rings]]>
Radiographic Contrast Agents And Contrast-induced Nephropathy All contrast agents have a basic structure of a benzene ring, which is composed of 6 joined carbon atoms, each of which has an attached hydrogen atom. Contrast media consist of triiodinated benzene rings, whereby 3 hydrogen atoms are replaced with attached iodine atoms. Monomers contain 1 triiodinated benzene ring, and dimers contain 2 triiodinated benzene rings]]> Sun, 27 Mar 2022 12:35:28 GMT /slideshow/contrastinduced-nephropathypptx/251439104 YogeshShilimkar@slideshare.net(YogeshShilimkar) Contrast-induced nephropathy.pptx YogeshShilimkar Radiographic Contrast Agents And Contrast-induced Nephropathy All contrast agents have a basic structure of a benzene ring, which is composed of 6 joined carbon atoms, each of which has an attached hydrogen atom. Contrast media consist of triiodinated benzene rings, whereby 3 hydrogen atoms are replaced with attached iodine atoms. Monomers contain 1 triiodinated benzene ring, and dimers contain 2 triiodinated benzene rings <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/contrast-inducednephropathy-220327123529-thumbnail.jpg?width=120&height=120&fit=bounds" /> Radiographic Contrast Agents And Contrast-induced Nephropathy All contrast agents have a basic structure of a benzene ring, which is composed of 6 joined carbon atoms, each of which has an attached hydrogen atom. Contrast media consist of triiodinated benzene rings, whereby 3 hydrogen atoms are replaced with attached iodine atoms. Monomers contain 1 triiodinated benzene ring, and dimers contain 2 triiodinated benzene rings

Contrast-induced nephropathy.pptx from Yogesh Shilimkar

]]> 1889 0 https://cdn.slidesharecdn.com/ss_thumbnails/contrast-inducednephropathy-220327123529-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 TOF.pptx /slideshow/tofpptx/251439002 tof-220327121537
Tetralogy of Fallot (TOF) is a congenital heart defect, which has four anatomical components— non-restrictive large subaortic ventricular septal defect (VSD), Infundibular stenosis, overriding aorta and right ventricular hypertrophy.]]>
Tetralogy of Fallot (TOF) is a congenital heart defect, which has four anatomical components— non-restrictive large subaortic ventricular septal defect (VSD), Infundibular stenosis, overriding aorta and right ventricular hypertrophy.]]> Sun, 27 Mar 2022 12:15:36 GMT /slideshow/tofpptx/251439002 YogeshShilimkar@slideshare.net(YogeshShilimkar) TOF.pptx YogeshShilimkar Tetralogy of Fallot (TOF) is a congenital heart defect, which has four anatomical components— non-restrictive large subaortic ventricular septal defect (VSD), Infundibular stenosis, overriding aorta and right ventricular hypertrophy. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/tof-220327121537-thumbnail.jpg?width=120&height=120&fit=bounds" /> Tetralogy of Fallot (TOF) is a congenital heart defect, which has four anatomical components— non-restrictive large subaortic ventricular septal defect (VSD), Infundibular stenosis, overriding aorta and right ventricular hypertrophy.

TOF.pptx from Yogesh Shilimkar

]]> 772 0 https://cdn.slidesharecdn.com/ss_thumbnails/tof-220327121537-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Brugada syndrome /slideshow/brugada-syndrome-238343866/238343866 brugadasyndrome-200831165737
Brugada syndrome]]>
Brugada syndrome]]> Mon, 31 Aug 2020 16:57:37 GMT /slideshow/brugada-syndrome-238343866/238343866 YogeshShilimkar@slideshare.net(YogeshShilimkar) Brugada syndrome YogeshShilimkar Brugada syndrome <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/brugadasyndrome-200831165737-thumbnail.jpg?width=120&height=120&fit=bounds" /> Brugada syndrome

Brugada syndrome from Yogesh Shilimkar

]]> 499 0 https://cdn.slidesharecdn.com/ss_thumbnails/brugadasyndrome-200831165737-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 The funny current /slideshow/the-funny-current-238343837/238343837 thefunnycurrent-200831165041
funny current in cardiology]]>
funny current in cardiology]]> Mon, 31 Aug 2020 16:50:41 GMT /slideshow/the-funny-current-238343837/238343837 YogeshShilimkar@slideshare.net(YogeshShilimkar) The funny current YogeshShilimkar funny current in cardiology <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/thefunnycurrent-200831165041-thumbnail.jpg?width=120&height=120&fit=bounds" /> funny current in cardiology

The funny current from Yogesh Shilimkar

]]> 728 0 https://cdn.slidesharecdn.com/ss_thumbnails/thefunnycurrent-200831165041-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Triangle of koch /slideshow/triangle-of-koch/238343757 triangleofkoch-200831163730
Triangle of koch]]>
Triangle of koch]]> Mon, 31 Aug 2020 16:37:30 GMT /slideshow/triangle-of-koch/238343757 YogeshShilimkar@slideshare.net(YogeshShilimkar) Triangle of koch YogeshShilimkar Triangle of koch <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/triangleofkoch-200831163730-thumbnail.jpg?width=120&height=120&fit=bounds" /> Triangle of koch

Triangle of koch from Yogesh Shilimkar

]]> 4208 0 https://cdn.slidesharecdn.com/ss_thumbnails/triangleofkoch-200831163730-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Bifurcation lesions and interventions /YogeshShilimkar/bifurcation-lesions-and-interventions bifurcationlesionsandintervention-dr-200730201029
management of bifurcation lesions]]>
management of bifurcation lesions]]> Thu, 30 Jul 2020 20:10:29 GMT /YogeshShilimkar/bifurcation-lesions-and-interventions YogeshShilimkar@slideshare.net(YogeshShilimkar) Bifurcation lesions and interventions YogeshShilimkar management of bifurcation lesions <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/bifurcationlesionsandintervention-dr-200730201029-thumbnail.jpg?width=120&height=120&fit=bounds" /> management of bifurcation lesions

Bifurcation lesions and interventions from Yogesh Shilimkar

]]> 866 0 https://cdn.slidesharecdn.com/ss_thumbnails/bifurcationlesionsandintervention-dr-200730201029-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Micro t wave alternans /slideshow/micro-t-wave-alternans/231171932 microtwavealternans-200331132442
Micro T wave alternans]]>
Micro T wave alternans]]> Tue, 31 Mar 2020 13:24:41 GMT /slideshow/micro-t-wave-alternans/231171932 YogeshShilimkar@slideshare.net(YogeshShilimkar) Micro t wave alternans YogeshShilimkar Micro T wave alternans <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/microtwavealternans-200331132442-thumbnail.jpg?width=120&height=120&fit=bounds" /> Micro T wave alternans

Micro t wave alternans from Yogesh Shilimkar

]]> 265 0 https://cdn.slidesharecdn.com/ss_thumbnails/microtwavealternans-200331132442-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Coronary intravascular lithotripsy and lasers/ IVL /slideshow/the-coronary-intravascular-lithotripsy-and-lasers/229745730 thecoronaryintravascularlithotripsy-200305161119
Coronary intravascular lithotripsy/coronary lithotripsy]]>
Coronary intravascular lithotripsy/coronary lithotripsy]]> Thu, 05 Mar 2020 16:11:19 GMT /slideshow/the-coronary-intravascular-lithotripsy-and-lasers/229745730 YogeshShilimkar@slideshare.net(YogeshShilimkar) Coronary intravascular lithotripsy and lasers/ IVL YogeshShilimkar Coronary intravascular lithotripsy/coronary lithotripsy <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/thecoronaryintravascularlithotripsy-200305161119-thumbnail.jpg?width=120&height=120&fit=bounds" /> Coronary intravascular lithotripsy/coronary lithotripsy

Coronary intravascular lithotripsy and lasers/ IVL from Yogesh Shilimkar

]]> 1529 0 https://cdn.slidesharecdn.com/ss_thumbnails/thecoronaryintravascularlithotripsy-200305161119-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Left atrial appendage closure /slideshow/left-atrial-appendage-closure/229745561 leftatrialappendageclosure-200305160733
LA appendage closure]]>
LA appendage closure]]> Thu, 05 Mar 2020 16:07:33 GMT /slideshow/left-atrial-appendage-closure/229745561 YogeshShilimkar@slideshare.net(YogeshShilimkar) Left atrial appendage closure YogeshShilimkar LA appendage closure <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/leftatrialappendageclosure-200305160733-thumbnail.jpg?width=120&height=120&fit=bounds" /> LA appendage closure

Left atrial appendage closure from Yogesh Shilimkar

]]> 2539 0 https://cdn.slidesharecdn.com/ss_thumbnails/leftatrialappendageclosure-200305160733-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Percutaneous mitral valve interventions for MR /slideshow/percutaneous-mitral-valve-interventions-for-mr/229745330 percutaneousmitralvalveinterventionsformr-yogesh-200305160230
TMVR]]>
TMVR]]> Thu, 05 Mar 2020 16:02:30 GMT /slideshow/percutaneous-mitral-valve-interventions-for-mr/229745330 YogeshShilimkar@slideshare.net(YogeshShilimkar) Percutaneous mitral valve interventions for MR YogeshShilimkar TMVR <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/percutaneousmitralvalveinterventionsformr-yogesh-200305160230-thumbnail.jpg?width=120&height=120&fit=bounds" /> TMVR

Percutaneous mitral valve interventions for MR from Yogesh Shilimkar

]]> 989 0 https://cdn.slidesharecdn.com/ss_thumbnails/percutaneousmitralvalveinterventionsformr-yogesh-200305160230-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Sglt 2 inhibiors in cardiovascular diseases /slideshow/sglt-2-inhibiors-in-cardiovascular-diseases/229745060 sglt2inhibiorsfinal-200305155655
SGLT 2 inhibitors]]>
SGLT 2 inhibitors]]> Thu, 05 Mar 2020 15:56:55 GMT /slideshow/sglt-2-inhibiors-in-cardiovascular-diseases/229745060 YogeshShilimkar@slideshare.net(YogeshShilimkar) Sglt 2 inhibiors in cardiovascular diseases YogeshShilimkar SGLT 2 inhibitors <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/sglt2inhibiorsfinal-200305155655-thumbnail.jpg?width=120&height=120&fit=bounds" /> SGLT 2 inhibitors

Sglt 2 inhibiors in cardiovascular diseases from Yogesh Shilimkar

]]> 3721 0 https://cdn.slidesharecdn.com/ss_thumbnails/sglt2inhibiorsfinal-200305155655-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 https://public.slidesharecdn.com/v2/images/profile-picture.png https://cdn.slidesharecdn.com/ss_thumbnails/oct-220327124849-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/octpptx/251439165 OCT.pptx https://cdn.slidesharecdn.com/ss_thumbnails/contrast-inducednephropathy-220327123529-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/contrastinduced-nephropathypptx/251439104 Contrast-induced nephr... https://cdn.slidesharecdn.com/ss_thumbnails/tof-220327121537-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/tofpptx/251439002 TOF.pptx